Panion & BF Biotech Inc. Statistics
Panion & BF Biotech Inc. (1760) Stock Statistics & Valuation Metrics
Total Valuation
Panion & BF Biotech Inc. has a market cap or net worth of TWD 4.20B. The enterprise value is TWD 5.36B.
- Market Cap
- TWD 4.20B
- Enterprise Value
- TWD 5.36B
Share Statistics
Panion & BF Biotech Inc. has 85,739,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 85,739,010
- Owned by Insiders
- ―
- Owned by Institutions
- 2.55%
Financial Efficiency
Panion & BF Biotech Inc.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.36%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 7.36%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 6.43M
- Profits Per Employee
- 592.43K
- Employee Count
- 321
- Asset Turnover
- 0.64
- Inventory Turnover
- 1.67
Valuation Ratios
The current PE Ratio of Panion & BF Biotech Inc. is 19.64. Panion & BF Biotech Inc.’s PEG ratio is 0.28.
- PE Ratio
- 19.64
- PS Ratio
- 2.00
- PB Ratio
- 2.25
- Price to FCF
- 22.37
- Price to Operating Cash Flow
- 12.68
- PEG Ratio
- 0.28
Income Statement
In the last 12 months, Panion & BF Biotech Inc. had revenue of 2.06B and earned 190.17M in profits. Earnings per share was 2.22.
- Revenue
- 2.06B
- Gross Profit
- 1.12B
- Operating Income
- 307.85M
- Pretax Income
- 294.04M
- Net Income
- 190.17M
- EBITDA
- 446.27M
- Earnings Per Share (EPS)
- 2.22
Cash Flow
In the last 12 months, operating cash flow was 333.17M and capital expenditures -144.22M, giving a free cash flow of 188.95M billion.
- Operating Cash Flow
- 333.17M
- Free Cash Flow
- 188.95M
- Free Cash Flow per Share
- 2.21
Dividends & Yields
Panion & BF Biotech Inc. pays an annual dividend of ―, resulting in a dividend yield of 4.09%
- Dividend Per Share
- ―
- Dividend Yield
- 4.09%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.47%
- Earnings Yield
- 5.09%
Stock Price Statistics
- Beta
- 0.29
- 52-Week Price Change
- -24.11%
- 50-Day Moving Average
- 53.65
- 200-Day Moving Average
- 58.76
- Relative Strength Index (RSI)
- 27.04
- Average Volume (3m)
- 113.71K
Important Dates
Panion & BF Biotech Inc. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Panion & BF Biotech Inc. as a current ratio of 1.45, with Debt / Equity ratio of 33.14%
- Current Ratio
- 1.45
- Quick Ratio
- 0.89
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- 0.42
- Interest Coverage Ratio
- 21.46
Taxes
In the past 12 months, Panion & BF Biotech Inc. has paid 103.87M in taxes.
- Income Tax
- 103.87M
- Effective Tax Rate
- 0.35
Enterprise Valuation
Panion & BF Biotech Inc. EV to EBITDA ratio is 9.35, with an EV/FCF ratio of 23.07.
- EV to Sales
- 2.07
- EV to EBITDA
- 9.35
- EV to Free Cash Flow
- 23.07
- EV to Operating Cash Flow
- 13.08
Balance Sheet
Panion & BF Biotech Inc. has TWD 471.42M in cash and marketable securities with TWD 603.26M in debt, giving a net cash position of -TWD 131.84M billion.
- Cash & Marketable Securities
- TWD 471.42M
- Total Debt
- TWD 603.26M
- Net Cash
- -TWD 131.84M
- Net Cash Per Share
- -TWD 1.54
- Tangible Book Value Per Share
- TWD 21.72
Margins
Gross margin is 52.85%, with operating margin of 15.03%, and net profit margin of 10.19%.
- Gross Margin
- 52.85%
- Operating Margin
- 15.03%
- Pretax Margin
- 15.15%
- Net Profit Margin
- 10.19%
- EBITDA Margin
- 22.10%
- EBIT Margin
- 15.44%
Analyst Forecast
The average price target for Panion & BF Biotech Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 4.99%
- EPS Growth Forecast
- 69.51%
